checkAd

     237  0 Kommentare SS Innovations International Announces Q1 2024 Company Updates - Seite 2

    About World Laparoscopy Hospital

    World Laparoscopy Hospital is a world-class academic institute for Minimal Access Surgery, renowned globally for its excellence. The institute has been accredited by the National Accreditation Board for Hospitals and Healthcare Providers (NABH). It is a scientific, clinical, and educational center that strives to enhance the quality of care for patients undergoing Minimal Access Surgery by setting high standards of laparoscopic and robotic surgical education, as well as clinical practice. World Laparoscopy Hospital's training institute has locations in Gurugram, India, the United Arab Emirates, and the United States of America. This institution complies with the guidelines established in the "Framework for Post-Residency Surgical Education and Training" and has been endorsed at the gold level by various international organizations, including WALS and ICRS. For more information, please visit: https://www.laparoscopyhospital.com

    About SS Innovations International, Inc.

    SS Innovations International, Inc. (OTC: SSII) is a developer of innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger part of the global population. SSII’s product range includes its proprietary “SSi Mantra” surgical robotic system, and “SSi Mudra”, its wide range of surgical instruments capable of supporting a variety of surgical procedures including robotic cardiac surgery. SSII’s business operations are headquartered in India and SSII has plans to expand the presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions, globally. For more information, visit SSII’s website at ssinnovations.com or LinkedIn for updates.

    About SSi Mantra

    Supporting advanced, affordable, and accessible robotic surgery, the SSi Mantra Surgical Robotic System provides the capabilities for multi-specialty usage including cardiothoracic, head and neck, gynecology, urology, general surgery and more. With its modular arm configuration, 3D 4K vision open-console design and superior ergonomics, the system engages with the surgeon and surgical teams to improve safety and efficiency during procedures. The SSi Mantra has received Indian Medical Device regulatory approval (CDSCO) and is clinically validated in India in more than 60 different types of surgical procedures. The Company has initiated the regulatory approval process in the United States and the EU, with approval anticipated in the second half of 2024 or 2025.

    Seite 2 von 3



    globenewswire
    0 Follower
    Autor folgen

    Weitere Artikel des Autors


    Verfasst von globenewswire
    SS Innovations International Announces Q1 2024 Company Updates - Seite 2 Significant milestones achieved for SSi Mantra Made-in-India surgical robotic system FORT LAUDERDALE, Fla., April 22, 2024 (GLOBE NEWSWIRE) - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of …